European Biotech’s Biggest News of 2018
With this year coming to a close, it’s now time to look back at the…
With this year coming to a close, it’s now time to look back at the…
Researchers at the Institut Pasteur were able to selectively kill the cells where HIV hides…
According to Phase I/IIa trial results from an Israeli biotech, an HIV drug reduced patients'…
A monthly antiviral injection may be as good as daily HIV drugs for suppressing infections,…
AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that…
In the fight against HIV, a number of therapeutic approaches are currently in development. But…
ViiV Healthcare has shown its monthly two-drug HIV treatment works as well as a daily…
Researchers in Spain have created a strain of genetically-engineered rice that could provide a cheap…
ViiV Healthcare reports promising data from two HIV treatments with two drugs instead of the…
UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce…
A new HIV vaccine is moving into a Phase IIb trial and could potentially protect…
ViiV Healthcare obtained positive Phase III results for its two-drug HIV treatment regimen, which could…